E. Jaros

发表

Accumulation of wild‐type p53 in meningiomas

D. Ellison, K. Gatter, J. Lunec, 1995, Neuropathology and applied neurobiology.

Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.

I G McKeith, E K Perry, R H Perry, 1999, Brain : a journal of neurology.

Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies

A. Swann, E. Perry, I. McKeith, 2000, Neurology.

Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine

E. Perry, R. Perry, E. Jaros, 1999, Neuroscience.

Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy

I. McKeith, G. Livingston, C. Katona, 2007, Journal of Neurology, Neurosurgery, and Psychiatry.

Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes

E. Perry, E. Jaros, R. Perry, 2003, Glia.

High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease

Robert W. Taylor, D. Turnbull, C. Morris, 2006, Nature Genetics.

Dementia with Lewy Bodies

Robert Perry, E. Perry, I. McKeith, 2007, Seminars in neurology.

Attenuation of Aβ deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking

Margaret A. Johnson, E. Perry, I. McKeith, 2005, Neuropathology and applied neurobiology.

The pathogenesis of multiple system atrophy: Past, present, and future

D. Burn, E. Jaros, 2000, Movement disorders : official journal of the Movement Disorder Society.

Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies

W. Honer, E. Perry, I. McKeith, 2013, Journal of neuropathology and experimental neurology.

Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis

Nick C Fox, Alan J. Thomas, D. Hernandez, 2020, Scientific Reports.

A harmonized classification system for FTLD-TDP pathology

J. Trojanowski, V. Lee, D. Mann, 2011, Acta Neuropathologica.

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system

J. Lunec, E. Jaros, R. Perry, 2002, British Journal of Cancer.

α-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases

J. Trojanowski, C. Duyckaerts, V. Lee, 2004, Acta Neuropathologica.

Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease

J. Trojanowski, B. Pillon, M. Grossman, 2004, Neurology.

Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.

E. Jaros, D. Middleton, R. Perry, 1998, Neuroreport.

PRIMARY SPINAL CORD NEURODEGENERATION IN LEBER HEREDITARY OPTIC NEUROPATHY

D. Birchall, S. Sawcer, R. Perry, 2007, Neurology.

Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions

Ian G. McKeith, Martin N. Rossor, Charles Duyckaerts, 2003, Neuroscience Letters.

Temporal lobe pathology of human patients with neurofilament inclusion disease

N. Cairns, R. Perry, E. Jaros, 2004, Neuroscience Letters.

A new dementia: Neurofilament inclusion body dementia

P. Lantos, N. Cairns, J. Lowe, 2002 .

Clinical presentations in monozygotic twins with dementia with Lewy bodies.

I. McKeith, K. Santacruz, E. Jaros, 2002, Journal of the American Medical Directors Association.

Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.

E. Perry, S. Pimlott, D. Wyper, 2004, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in α-synuclein expression

M. Cookson, E. Perry, R. Perry, 2002, Neuroscience Letters.

Dementia with Lewy Bodies: What is the neuropathological basis of dementia associated with Lewy bodies?

P. Kelly, E. Perry, C. Morris, 1996 .

Nuclear carrier and RNA‐binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes

D. Neary, N. Cairns, D. Mann, 2013, Neuropathology and applied neurobiology.

Medial temporal lobe atrophy on MRI differentiates Alzheimer’s disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological veriﬁcation of diagnosis

R. Perry, R. Barber, R. Kalaria, 2009 .

ATYPICAL AXON‐SCHWANN CELL RELATIONSHIPS IN THE COMMON PERONEAL NERVE OF THE DYSTROPHIC MOUSE: AN ULTRASTRUCTURAL STUDY

E. Jaros, W. Bradley, 1979, Neuropathology and applied neurobiology.

Genetically determined defect of Schwann cell basement membrane in dystrophic mouse

E. Jaros, W. Bradley, M. Cullen, 1975, Nature.

Edinburgh Research Explorer Loss of myelin-associated glycoprotein in kearns-sayre syndrome

S. Dimauro, N. Lax, D. Turnbull, 2018 .

The relationship between mitochondria and α-synuclein-A study of single substantia nigra neurons

I. McKeith, N. Lax, D. Turnbull, 2011 .

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C. Fox, Pietro Pietrini, Alexander Gerhard, 2018, Nature Medicine.

Genetic variation across RNA metabolism and cell death gene networks is implicated in the semantic variant of primary progressive aphasia

M. Nalls, A. Ramasamy, P. Pietrini, 2019, Scientific Reports.

Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsy.

R. Whittaker, E. Jaros, H. Willison, 2014, Journal of neuromuscular diseases.

Effects of tenotomy on muscle histology and energy metabolism in normal and dystrophic mice

E. Jaros, N. Watmough, R. Lane, 1989, Journal of the Neurological Sciences.

Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse

E. Jaros, M. Cullen, 2004, Acta Neuropathologica.

INVOLVEMENT OF PERIPHERAL AND CENTRAL NERVES IN MURINE DYSTROPHY *

E. Jaros, W. Bradley, 1979, Annals of the New York Academy of Sciences.

Mitotic percentage index: a new prognostic factor for childhood medulloblastoma.

E. Jaros, J. Lunec, R. Perry, 1997, European journal of cancer.

Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.

R. Perry, E. Jaros, R. Perry, 1995, British Journal of Cancer.

THE NODES OF RANVIER IN THE NERVES OF MICE WITH MUSCULAR DYSTROPHY

E. Jaros, W. Bradley, M. Jenkison, 1977, Journal of neuropathology and experimental neurology.

Defective differentiation of peripheral nerves in the dystrophic mouse.

E. Jaros, M. Jenkison, 1983, Brain research.

Quantitative studies of the abnormal axon-Schwann cell relationship in the peripheral motor and sensory nerves of the dystrophic mouse

E. Jaros, M. Jenkison, 1983, Brain Research.

Spontaneous electrical activity in muscles of dystrophic (dy/dy) mice

E. Jaros, J. Harris, D. Johnstone, 1986, Journal of the Neurological Sciences.

Axoplasmic flow in axonal neuropathies. II. Axoplasmic flow in mice with motor neuron disease and muscular dystrophy.

E. Jaros, W. Bradley, 1973, Brain : a journal of neurology.

Prognostic factors in medulloblastoma

E. Jaros, R. Perry, A. Pearson, 1992, The Lancet.

Frontotemporal lobar degeneration in a very young patient is associated with fused in sarcoma (FUS) pathological changes

T. Griffiths, D. Mann, R. Perry, 2012, Neuropathology and applied neurobiology.

Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03

P. Ince, E. Jaros, D. Middleton, 1999, Neuroscience Letters.

Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals

E. Perry, R. Perry, E. Jaros, 2004, Neuropathology and applied neurobiology.

Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380

D Wyper, E K Perry, R H Perry, 2004, Neuropsychopharmacology.

Nicotinic receptor abnormalities in the cerebellar cortex in autism.

C Martin-Ruiz, E. Perry, P. Iversen, 2002, Brain : a journal of neurology.

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.

R. Perry, A. Mendelow, E. Jaros, 1992, British Journal of Cancer.

Clinical neurochemistry: developments in dementia research based on brain bank material

E. Perry, M. Griffiths, I. McKeith, 1998, Journal of Neural Transmission.

p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.

J. Lunec, E. Jaros, R. Perry, 1993, British Journal of Cancer.

Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes

Nick C Fox, Alan J. Thomas, D. Hernandez, 2021, Biological Psychiatry.

The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene

D. Neary, T. Griffiths, D. Mann, 2011, Acta Neuropathologica.

Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement

D. Turnbull, R. Perry, R. Lightowlers, 2006, Neuropathology and applied neurobiology.

across RNA cell death gene networks is implicated in the semantic variant of primary progressive aphasia.

L. Ferrucci, A. Ramasamy, E. Haan, 2019 .

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

E. Haan, P. Pietrini, R. Petersen, 2017, Scientific Reports.

D. Hernandez, M. Nalls, L. Ferrucci, 2017, bioRxiv.

Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death

M. Elstner, D. Turnbull, C. Morris, 2011, Acta Neuropathologica.

Frontotemporal dementia and its subtypes: a genome-wide association study

Alexander Gerhard, Adrian Danek, Luigi Ferrucci, 2014, The Lancet Neurology.

Sensory neuronopathy in patients harbouring recessive polymerase γ mutations.

Robert W. Taylor, N. Lax, D. Turnbull, 2012, Brain : a journal of neurology.

Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology

Alan J. Thomas, J. O'Brien, E. Jaros, 2001, Biological Psychiatry.

Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum

E. Perry, R. Perry, E. Jaros, 2002, Neuroscience.

Visual hallucinations are associated with lower αbungarotoxin binding in dementia with Lewy bodies

E. Perry, P. Lantos, N. Cairns, 2001, Pharmacology Biochemistry and Behavior.

Loss of myelin-associated glycoprotein in kearns-sayre syndrome.

Robert W. Taylor, S. Dimauro, N. Lax, 2012, Archives of neurology.

Quantification of Alzheimer pathology in ageing and dementia: age‐related accumulation of amyloid‐β(42) peptide in vascular dementia

C. Ballard, R. Perry, R. Kalaria, 2006, Neuropathology and applied neurobiology.

alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.

J. Trojanowski, C. Duyckaerts, V. Lee, 2004, The American journal of pathology.

Mitochondrial DNA deletions cause the biochemical defect observed in Alzheimer's disease

D. Turnbull, K. J. Krishnan, E. Jaros, 2012, Neurobiology of Aging.

Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype

Julie S. Snowden, Robert H. Perry, Atik Baborie, 2006, Acta Neuropathologica.

Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology

E. Perry, E. Jaros, R. Perry, 2004, Journal of the Neurological Sciences.

Delusions associated with elevated muscarinic binding in dementia with Lewy bodies

E. Perry, I. McKeith, J. O'Brien, 2000, Annals of neurology.

Microangiopathy in the cerebellum of patients with mitochondrial DNA disease

Robert W. Taylor, N. Lax, D. Turnbull, 2012, Brain : a journal of neurology.

Neurodegeneration in Primary Mitochondrial Disorders

N. Lax, E. Jaros, 2012 .

A prospectively studied clinicopathological case of ‘vascular depression’

Alan J. Thomas, P. English, E. Jaros, 2003, International Journal of Geriatric Psychiatry.

Cerebellar Ataxia in Patients With Mitochondrial DNA Disease: A Molecular Clinicopathological Study

Robert W. Taylor, N. Lax, D. Turnbull, 2012, Journal of neuropathology and experimental neurology.

The Impact of Pathogenic Mitochondrial DNA Mutations on Substantia Nigra Neurons

N. Lax, D. Turnbull, E. Jaros, 2013, The Journal of Neuroscience.

Mutation screening in exons 3 and 4 of α‐synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases

E. Jaros, D. Middleton, R. Perry, 1998 .

Distribution of histamine H3‐receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases

E. Perry, R. Perry, E. Jaros, 1999, The European journal of neuroscience.

Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex

E. Perry, P. Lantos, I. McKeith, 2002, Consciousness and Cognition.

Development of the amyelinated lesion in the ventral root of the dystrophic mouse Ultrastructural, quantitative and autoradiographic study

E. Jaros, W. Bradley, 1978, Journal of the Neurological Sciences.

Quantitative neurodegenerative pathology does not explain the degree of hippocampal atrophy on MRI in degenerative dementia

R. Perry, R. Barber, E. Jaros, 2012, International journal of geriatric psychiatry.

Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

J T O'Brien, R N Kalaria, E B Mukaetova-Ladinska, 2009, Brain : a journal of neurology.

Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia.

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Nature Medicine.

Frontotemporal dementia in elderly individuals.

T. Griffiths, I. McKeith, D. Burn, 2012, Archives of neurology.

Pathological correlates of frontotemporal lobar degeneration in the elderly

D. Neary, T. Griffiths, I. McKeith, 2011, Acta Neuropathologica.

A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers

Nick C Fox, Alan J. Thomas, D. Hernandez, 2018, Brain : a journal of neurology.

Accumulation of dipeptide repeat proteins predates that of TDP‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene

T. Griffiths, I. McKeith, D. Burn, 2015, Neuropathology and applied neurobiology.

Alpha- and Gamma-Synuclein Proteins Are Present in Cerebrospinal Fluid and Are Increased in Aged Subjects with Neurodegenerative and Vascular Changes

I. McKeith, C. Brayne, J. Xuereb, 2008, Dementia and Geriatric Cognitive Disorders.

Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.

J. Buxbaum, V. Haroutunian, E. Perry, 2000, European journal of pharmacology.

Depression in late life, cognitive decline and white matter pathology in two clinico‐pathologically investigated cases

J. Grace, R. Perry, E. Jaros, 2001, International journal of geriatric psychiatry.

Cholinergic and Monoaminergic Correlates of Clinical Symptoms in Dementia with Lewy Bodies

E. Perry, I. McKeith, C. Ballard, 2002 .

Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.

Catherine Joachim, E. Perry, I. McKeith, 2004, The American journal of psychiatry.

Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease

John O'Brien, Robert H. Perry, Mary Johnson, 2003, Journal of Chemical Neuroanatomy.

Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease

I. McKeith, G. Livingston, C. Katona, 2004, Neurology.

Alpha‐synuclein pathology and Parkinsonism associated with POLG1 mutations and multiple mitochondrial DNA deletions

D. Turnbull, K. J. Krishnan, R. Perry, 2009, Neuropathology and applied neurobiology.

What are the relations between Lewy body disease and AD?

I. McKeith, C. Morris, J. Grace, 1998, Journal of neural transmission. Supplementum.

Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS

Nick C Fox, D. Hernandez, M. Nalls, 2017, Scientific Reports.

Early-onset cataracts, spastic paraparesis, and ataxia caused by a novel mitochondrial tRNAGlu (MT-TE) gene mutation causing severe complex I deficiency: a clinical, molecular, and neuropathologic study.

Robert W. Taylor, N. Lax, D. Turnbull, 2013, Journal of neuropathology and experimental neurology.

Multiple system atrophy: cellular and molecular pathology

D. Burn, E. Jaros, 2001, Molecular pathology : MP.

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load

Alan J. Thomas, I. McKeith, D. Lett, 2015, Neurology.

Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene

I. McKeith, M. Elstner, D. Turnbull, 2009, Annals of neurology.

What's in a name? Neuronal intermediate filament inclusion disease (NIFID), frontotemporal lobar degeneration-intermediate filament (FTLD-IF) or frontotemporal lobar degeneration-fused in sarcoma (FTLD-FUS)?

D. Mann, E. Jaros, A. Baborie, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia

J. O'Brien, R. Barber, E. Jaros, 2012, Neurobiology of Aging.

SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies

Janel O. Johnson, I G McKeith, D J Burn, 2004, Neurology.

Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus

E. Perry, R. Perry, E. Jaros, 2003, Journal of Chemical Neuroanatomy.

Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes

I. McKeith, J. O'Brien, C. Ballard, 2000, Dementia and Geriatric Cognitive Disorders.

Atheromatous disease in small intracerebral vessels, microinfarcts and dementia

J. O'Brien, R. Perry, R. Kalaria, 2012, Neuropathology and applied neurobiology.

Elderly individuals with FTLD.

T. Griffiths, I. McKeith, D. Burn, 2013, JAMA neurology.

P53 overexpression in head and neck carcinoma and radiotherapy results.

J. Lunec, E. Jaros, S. Awwad, 1996, International Journal of Radiation Oncology, Biology, Physics.

CXCR4 involvement in neurodegenerative diseases

O. Andreassen, G. Schellenberg, A. Dale, 2017, bioRxiv.

Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's disease and Parkinson's disease cases

E. Perry, E. Jaros, P. Ince, 1999 .

Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline

E. Perry, I. McKeith, C. Holmes, 2007, Synapse.